Plethysmographic Pulse-contour and Pulse-wave-transit-times for Haemodynamic Evaluation in Bleeding Simulation
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Mar 22, 2018
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Offered patient information and written informed consent
- • Existence of valid health insurance
- • Male gender
- Exclusion Criteria:
- • Patients aged less than 18 years or more than 40 years
- • Inability of German language use
- • Lacking willingness to save and hand out data within the study
- • Evidence of a chronic disease (cardio-vascular, renal, pulmonary, neurological, metabolic, gastro-intestinal)
- • Chronic medication
- • Signs of a reduced cardiorespiratory capacity
- • Signs of an acute illness
- • Participation in a prospective intervention trial during the study period
- • Anamnestic hints for syncope or disposition to hypotension
- • Signs of arterial hypertension
- • Signs of inguinal hernia
- • Relevant pathologies in the baseline examination of the transthoracic echocardiography
- • For the bio-impedance measurements: heart defibrillator
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Aarne Feldheiser, MD, PhD
Principal Investigator
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow Klinikum, Charité - University Medicine Berlin Berlin, Germany, 13353 Berlin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials